| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hematopoietic Stem Cells | 34 | 2025 | 556 | 10.500 |
Why?
|
| Hematopoiesis | 18 | 2025 | 225 | 5.590 |
Why?
|
| Hematologic Diseases | 5 | 2024 | 82 | 2.960 |
Why?
|
| Interferon-gamma | 6 | 2024 | 538 | 1.960 |
Why?
|
| Cell Differentiation | 12 | 2025 | 1981 | 1.610 |
Why?
|
| Bone Marrow | 7 | 2022 | 332 | 1.400 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 3 | 2022 | 158 | 1.380 |
Why?
|
| Antigens, CD | 2 | 2024 | 435 | 1.370 |
Why?
|
| Gastrointestinal Microbiome | 4 | 2024 | 818 | 1.250 |
Why?
|
| Interferon Type I | 2 | 2022 | 114 | 1.150 |
Why?
|
| Myeloid Cells | 3 | 2025 | 119 | 1.120 |
Why?
|
| Inflammation | 7 | 2024 | 1521 | 1.050 |
Why?
|
| Interferon-alpha | 4 | 2018 | 246 | 1.040 |
Why?
|
| GPI-Linked Proteins | 2 | 2024 | 107 | 1.030 |
Why?
|
| Animals | 42 | 2025 | 35053 | 1.010 |
Why?
|
| Bone Marrow Cells | 5 | 2021 | 263 | 1.000 |
Why?
|
| Mice | 32 | 2025 | 18562 | 0.980 |
Why?
|
| Immunity, Innate | 2 | 2025 | 413 | 0.950 |
Why?
|
| Epigenesis, Genetic | 6 | 2025 | 757 | 0.920 |
Why?
|
| Bone Marrow Diseases | 2 | 2022 | 41 | 0.890 |
Why?
|
| Phagocytosis | 1 | 2025 | 193 | 0.860 |
Why?
|
| Clonal Evolution | 2 | 2025 | 49 | 0.860 |
Why?
|
| Immunologic Memory | 1 | 2025 | 199 | 0.850 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2025 | 615 | 0.840 |
Why?
|
| Cell Proliferation | 8 | 2018 | 2510 | 0.840 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 2023 | 9 | 0.820 |
Why?
|
| GTP-Binding Proteins | 3 | 2019 | 172 | 0.820 |
Why?
|
| Mutation | 10 | 2025 | 6249 | 0.810 |
Why?
|
| Central Nervous System | 1 | 2025 | 284 | 0.810 |
Why?
|
| Anemia | 2 | 2017 | 349 | 0.800 |
Why?
|
| MAP Kinase Signaling System | 1 | 2024 | 312 | 0.790 |
Why?
|
| Mice, Knockout | 7 | 2024 | 3867 | 0.780 |
Why?
|
| Signal Transduction | 13 | 2023 | 4720 | 0.770 |
Why?
|
| Thrombocythemia, Essential | 3 | 2021 | 33 | 0.770 |
Why?
|
| Anti-Bacterial Agents | 7 | 2021 | 2575 | 0.770 |
Why?
|
| Mice, Inbred C57BL | 15 | 2025 | 4755 | 0.760 |
Why?
|
| Immunomodulation | 1 | 2022 | 79 | 0.730 |
Why?
|
| Interferons | 2 | 2021 | 142 | 0.730 |
Why?
|
| Hematopoietic Cell Growth Factors | 1 | 2020 | 11 | 0.680 |
Why?
|
| Busulfan | 1 | 2020 | 44 | 0.670 |
Why?
|
| Stem Cells | 2 | 2024 | 735 | 0.670 |
Why?
|
| Streptococcal Infections | 3 | 2022 | 247 | 0.670 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2020 | 25 | 0.670 |
Why?
|
| Asthma | 6 | 2025 | 770 | 0.670 |
Why?
|
| Immunologic Factors | 1 | 2021 | 184 | 0.620 |
Why?
|
| Disease Progression | 2 | 2025 | 2226 | 0.620 |
Why?
|
| DNA-Binding Proteins | 2 | 2025 | 2066 | 0.600 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2021 | 234 | 0.590 |
Why?
|
| Polycythemia Vera | 2 | 2018 | 41 | 0.590 |
Why?
|
| STAT1 Transcription Factor | 2 | 2016 | 75 | 0.590 |
Why?
|
| Membrane Glycoproteins | 1 | 2020 | 421 | 0.580 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 2 | 2025 | 31 | 0.580 |
Why?
|
| Hydroxyurea | 2 | 2018 | 85 | 0.580 |
Why?
|
| Dysbiosis | 2 | 2024 | 141 | 0.570 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 7 | 2024 | 1191 | 0.560 |
Why?
|
| Bromodeoxyuridine | 1 | 2018 | 57 | 0.560 |
Why?
|
| Neoplasms | 2 | 2023 | 2942 | 0.560 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 2017 | 15 | 0.550 |
Why?
|
| Erythroid Precursor Cells | 1 | 2017 | 24 | 0.550 |
Why?
|
| Lymphocytic Choriomeningitis | 1 | 2017 | 12 | 0.550 |
Why?
|
| Abscess | 1 | 2019 | 140 | 0.550 |
Why?
|
| Alzheimer Disease | 1 | 2025 | 863 | 0.550 |
Why?
|
| Histamine | 1 | 2017 | 49 | 0.550 |
Why?
|
| Flow Cytometry | 2 | 2018 | 806 | 0.540 |
Why?
|
| Erythropoiesis | 1 | 2017 | 43 | 0.540 |
Why?
|
| Environmental Exposure | 1 | 2019 | 236 | 0.540 |
Why?
|
| Sepsis | 1 | 2022 | 519 | 0.530 |
Why?
|
| Humans | 52 | 2025 | 131987 | 0.520 |
Why?
|
| Microbiota | 1 | 2022 | 435 | 0.510 |
Why?
|
| Thrombocytosis | 1 | 2016 | 33 | 0.510 |
Why?
|
| Leukopenia | 1 | 2016 | 47 | 0.510 |
Why?
|
| Cytokines | 7 | 2022 | 1367 | 0.490 |
Why?
|
| Osteomyelitis | 1 | 2019 | 214 | 0.490 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2022 | 899 | 0.480 |
Why?
|
| MicroRNAs | 2 | 2025 | 917 | 0.470 |
Why?
|
| Stress, Physiological | 1 | 2017 | 261 | 0.470 |
Why?
|
| Cat-Scratch Disease | 1 | 2015 | 30 | 0.460 |
Why?
|
| Disease Management | 1 | 2019 | 564 | 0.450 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2015 | 102 | 0.450 |
Why?
|
| Clone Cells | 3 | 2025 | 179 | 0.430 |
Why?
|
| Epithelium | 1 | 2015 | 352 | 0.430 |
Why?
|
| Celiac Disease | 3 | 2019 | 73 | 0.420 |
Why?
|
| Candidiasis | 2 | 2019 | 138 | 0.420 |
Why?
|
| Virus Diseases | 1 | 2015 | 291 | 0.370 |
Why?
|
| Receptors, Interferon | 1 | 2011 | 23 | 0.360 |
Why?
|
| Disease Models, Animal | 8 | 2025 | 4675 | 0.360 |
Why?
|
| Alchemy | 1 | 2011 | 3 | 0.350 |
Why?
|
| Respiratory Tract Infections | 2 | 2025 | 294 | 0.350 |
Why?
|
| Cell Lineage | 4 | 2020 | 361 | 0.350 |
Why?
|
| Dermis | 1 | 2011 | 27 | 0.350 |
Why?
|
| Graft vs Host Disease | 3 | 2024 | 621 | 0.340 |
Why?
|
| Immunity | 1 | 2011 | 183 | 0.340 |
Why?
|
| Science | 1 | 2011 | 37 | 0.340 |
Why?
|
| Epithelial Cells | 1 | 2015 | 905 | 0.330 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 2 | 2021 | 73 | 0.330 |
Why?
|
| Homeostasis | 4 | 2018 | 727 | 0.320 |
Why?
|
| Artificial Intelligence | 2 | 2025 | 296 | 0.320 |
Why?
|
| Leprostatic Agents | 1 | 2009 | 2 | 0.310 |
Why?
|
| Lipopeptides | 1 | 2009 | 36 | 0.310 |
Why?
|
| Leprosy | 1 | 2009 | 20 | 0.310 |
Why?
|
| Fungemia | 1 | 2009 | 23 | 0.310 |
Why?
|
| Adoption | 1 | 2009 | 18 | 0.300 |
Why?
|
| Cell Cycle | 4 | 2018 | 610 | 0.300 |
Why?
|
| Echinocandins | 1 | 2009 | 43 | 0.300 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2009 | 138 | 0.290 |
Why?
|
| Female | 23 | 2025 | 70633 | 0.280 |
Why?
|
| Cell Division | 2 | 2020 | 745 | 0.280 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2009 | 123 | 0.280 |
Why?
|
| Tuberculosis | 2 | 2011 | 557 | 0.270 |
Why?
|
| Streptococcus pyogenes | 3 | 2005 | 79 | 0.270 |
Why?
|
| Male | 21 | 2025 | 64856 | 0.270 |
Why?
|
| Dioxygenases | 2 | 2025 | 65 | 0.270 |
Why?
|
| Hematologic Neoplasms | 2 | 2021 | 294 | 0.260 |
Why?
|
| Infant, Premature, Diseases | 1 | 2009 | 252 | 0.260 |
Why?
|
| Macrophages | 2 | 2024 | 694 | 0.260 |
Why?
|
| Fibroblasts | 1 | 2011 | 880 | 0.260 |
Why?
|
| Antifungal Agents | 1 | 2009 | 311 | 0.250 |
Why?
|
| Janus Kinase 2 | 2 | 2018 | 132 | 0.240 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2023 | 569 | 0.230 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2025 | 37 | 0.230 |
Why?
|
| Bone Marrow Stromal Antigen 2 | 1 | 2024 | 5 | 0.230 |
Why?
|
| Glutathione Peroxidase | 2 | 2004 | 47 | 0.220 |
Why?
|
| Bacteroides | 1 | 2024 | 37 | 0.220 |
Why?
|
| Membrane Microdomains | 1 | 2024 | 61 | 0.220 |
Why?
|
| Pulmonary Fibrosis | 1 | 2025 | 112 | 0.210 |
Why?
|
| Microglia | 1 | 2025 | 139 | 0.210 |
Why?
|
| Interleukin-1alpha | 1 | 2023 | 10 | 0.210 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 2023 | 27 | 0.200 |
Why?
|
| Autoimmunity | 2 | 2024 | 182 | 0.200 |
Why?
|
| Cigarette Smoking | 1 | 2023 | 80 | 0.190 |
Why?
|
| Cell Self Renewal | 2 | 2025 | 49 | 0.190 |
Why?
|
| Peroxidases | 2 | 2005 | 29 | 0.180 |
Why?
|
| Streptococcus | 1 | 2022 | 63 | 0.180 |
Why?
|
| Minnesota | 5 | 2021 | 179 | 0.180 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2011 | 2849 | 0.180 |
Why?
|
| Mice, SCID | 1 | 2022 | 606 | 0.180 |
Why?
|
| Gene Expression | 3 | 2016 | 1567 | 0.180 |
Why?
|
| Sarcoma, Myeloid | 1 | 2021 | 11 | 0.180 |
Why?
|
| Leukemia, B-Cell | 1 | 2021 | 25 | 0.180 |
Why?
|
| Gene Expression Profiling | 4 | 2019 | 1875 | 0.180 |
Why?
|
| E-Selectin | 1 | 2020 | 39 | 0.170 |
Why?
|
| Chemokine CXCL12 | 1 | 2020 | 36 | 0.170 |
Why?
|
| Radiation Chimera | 1 | 2020 | 18 | 0.170 |
Why?
|
| Inhalation Exposure | 1 | 2020 | 36 | 0.170 |
Why?
|
| Interleukin-6 | 1 | 2022 | 435 | 0.170 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2022 | 116 | 0.170 |
Why?
|
| Smoke | 1 | 2020 | 66 | 0.170 |
Why?
|
| Fluorouracil | 1 | 2020 | 139 | 0.160 |
Why?
|
| Intestines | 1 | 2024 | 612 | 0.160 |
Why?
|
| Stem Cell Transplantation | 1 | 2022 | 246 | 0.160 |
Why?
|
| Toll-Like Receptors | 2 | 2018 | 84 | 0.160 |
Why?
|
| Tobacco Products | 1 | 2020 | 72 | 0.160 |
Why?
|
| Hydrogen Peroxide | 1 | 2000 | 121 | 0.160 |
Why?
|
| Repressor Proteins | 2 | 2005 | 826 | 0.160 |
Why?
|
| Thyroiditis, Suppurative | 1 | 2019 | 5 | 0.160 |
Why?
|
| Thyroid Crisis | 1 | 2019 | 6 | 0.160 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 3355 | 0.160 |
Why?
|
| Transglutaminases | 1 | 2019 | 26 | 0.160 |
Why?
|
| Antineoplastic Agents | 2 | 2021 | 1826 | 0.160 |
Why?
|
| Protein Phosphatase 2C | 1 | 2019 | 60 | 0.160 |
Why?
|
| Candida tropicalis | 1 | 2019 | 17 | 0.160 |
Why?
|
| Social Class | 2 | 2022 | 207 | 0.160 |
Why?
|
| Community Health Centers | 1 | 2019 | 40 | 0.160 |
Why?
|
| Mycobacterium avium | 2 | 2016 | 16 | 0.150 |
Why?
|
| Bacterial Proteins | 2 | 2005 | 929 | 0.150 |
Why?
|
| Micronutrients | 1 | 2019 | 74 | 0.150 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2023 | 377 | 0.150 |
Why?
|
| Nod1 Signaling Adaptor Protein | 1 | 2018 | 2 | 0.150 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 2019 | 52 | 0.150 |
Why?
|
| Loss of Function Mutation | 1 | 2019 | 160 | 0.140 |
Why?
|
| Models, Immunological | 1 | 2018 | 37 | 0.140 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2018 | 60 | 0.140 |
Why?
|
| Pneumonia | 1 | 2022 | 335 | 0.140 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 692 | 0.140 |
Why?
|
| Nutrition Disorders | 1 | 2018 | 32 | 0.140 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2021 | 633 | 0.140 |
Why?
|
| Incidence | 6 | 2023 | 3360 | 0.140 |
Why?
|
| Infant | 6 | 2025 | 13109 | 0.140 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2018 | 100 | 0.140 |
Why?
|
| Biomedical Research | 1 | 2023 | 550 | 0.130 |
Why?
|
| Nutritional Status | 1 | 2019 | 326 | 0.130 |
Why?
|
| Granulocytes | 1 | 2016 | 69 | 0.130 |
Why?
|
| Germ-Free Life | 1 | 2016 | 65 | 0.130 |
Why?
|
| Fractures, Bone | 1 | 2019 | 207 | 0.130 |
Why?
|
| Neutropenia | 1 | 2018 | 205 | 0.130 |
Why?
|
| DNA Damage | 1 | 2019 | 512 | 0.130 |
Why?
|
| Autoantibodies | 1 | 2019 | 459 | 0.130 |
Why?
|
| Polyethylene Glycols | 1 | 2018 | 250 | 0.130 |
Why?
|
| Child | 9 | 2024 | 25772 | 0.130 |
Why?
|
| West Nile Fever | 1 | 2018 | 139 | 0.120 |
Why?
|
| Child, Preschool | 6 | 2025 | 14818 | 0.120 |
Why?
|
| Immunocompromised Host | 1 | 2018 | 307 | 0.120 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2016 | 106 | 0.120 |
Why?
|
| Graft Survival | 1 | 2018 | 475 | 0.120 |
Why?
|
| Hemoglobinuria, Paroxysmal | 1 | 2016 | 25 | 0.120 |
Why?
|
| Apoptosis | 1 | 2022 | 1899 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2016 | 64 | 0.120 |
Why?
|
| GATA2 Transcription Factor | 1 | 2016 | 46 | 0.120 |
Why?
|
| Anemia, Aplastic | 1 | 2016 | 62 | 0.120 |
Why?
|
| Zinc Fingers | 1 | 2016 | 124 | 0.120 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2016 | 145 | 0.120 |
Why?
|
| Glomerulonephritis, Membranoproliferative | 1 | 2015 | 19 | 0.120 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2016 | 88 | 0.120 |
Why?
|
| Methanococcus | 1 | 1995 | 2 | 0.120 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 2462 | 0.110 |
Why?
|
| Societies, Scientific | 1 | 2014 | 26 | 0.110 |
Why?
|
| Immunophenotyping | 2 | 2016 | 344 | 0.110 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2014 | 45 | 0.110 |
Why?
|
| Transcription Factors | 2 | 2005 | 2567 | 0.110 |
Why?
|
| Stem Cell Niche | 1 | 2014 | 58 | 0.110 |
Why?
|
| Resting Phase, Cell Cycle | 1 | 2014 | 18 | 0.110 |
Why?
|
| Hematology | 1 | 2014 | 43 | 0.110 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2014 | 38 | 0.110 |
Why?
|
| Genes, Bacterial | 1 | 1995 | 217 | 0.110 |
Why?
|
| Retrospective Studies | 7 | 2021 | 17298 | 0.110 |
Why?
|
| Risk Factors | 3 | 2025 | 10829 | 0.110 |
Why?
|
| Treatment Failure | 1 | 2015 | 360 | 0.110 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2018 | 326 | 0.110 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2016 | 449 | 0.100 |
Why?
|
| Sequence Deletion | 1 | 2016 | 532 | 0.100 |
Why?
|
| B-Lymphocytes | 1 | 2016 | 542 | 0.100 |
Why?
|
| Brain | 1 | 2025 | 3196 | 0.100 |
Why?
|
| Protein Kinases | 1 | 1995 | 331 | 0.100 |
Why?
|
| Multiprotein Complexes | 1 | 2014 | 202 | 0.100 |
Why?
|
| Adolescent | 7 | 2024 | 20508 | 0.100 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 816 | 0.090 |
Why?
|
| Antiviral Agents | 1 | 2018 | 823 | 0.090 |
Why?
|
| Organoids | 2 | 2025 | 300 | 0.090 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 447 | 0.090 |
Why?
|
| Receptors, Cytokine | 1 | 2011 | 67 | 0.090 |
Why?
|
| Bone Marrow Transplantation | 2 | 2011 | 618 | 0.090 |
Why?
|
| Smoking | 1 | 2016 | 940 | 0.090 |
Why?
|
| Pluripotent Stem Cells | 1 | 2011 | 79 | 0.080 |
Why?
|
| Texas | 1 | 2019 | 3646 | 0.080 |
Why?
|
| Adult | 4 | 2024 | 31549 | 0.080 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2011 | 295 | 0.080 |
Why?
|
| Aging | 3 | 2025 | 1255 | 0.080 |
Why?
|
| Cell Culture Techniques | 1 | 2011 | 289 | 0.080 |
Why?
|
| Multipotent Stem Cells | 2 | 2025 | 26 | 0.080 |
Why?
|
| Case-Control Studies | 3 | 2022 | 3421 | 0.080 |
Why?
|
| Ethiopia | 1 | 2009 | 23 | 0.080 |
Why?
|
| Infant, Newborn | 4 | 2021 | 8500 | 0.080 |
Why?
|
| Liver Function Tests | 1 | 2009 | 105 | 0.080 |
Why?
|
| Aspartate Aminotransferases | 1 | 2009 | 83 | 0.080 |
Why?
|
| Genetic Markers | 1 | 2011 | 620 | 0.080 |
Why?
|
| Amphotericin B | 1 | 2009 | 91 | 0.070 |
Why?
|
| Alanine Transaminase | 1 | 2009 | 159 | 0.070 |
Why?
|
| HEK293 Cells | 1 | 2011 | 793 | 0.070 |
Why?
|
| Prednisone | 1 | 2009 | 252 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 1290 | 0.070 |
Why?
|
| Aged | 4 | 2023 | 21301 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 1045 | 0.070 |
Why?
|
| Regeneration | 2 | 2024 | 227 | 0.070 |
Why?
|
| Autophagy | 1 | 2011 | 425 | 0.070 |
Why?
|
| Crohn Disease | 1 | 2011 | 290 | 0.070 |
Why?
|
| Muscle, Skeletal | 1 | 2014 | 1032 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 1722 | 0.070 |
Why?
|
| Cholestasis | 1 | 2009 | 157 | 0.070 |
Why?
|
| Molecular Sequence Data | 4 | 2005 | 3834 | 0.060 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2009 | 304 | 0.060 |
Why?
|
| Treatment Outcome | 2 | 2019 | 12874 | 0.060 |
Why?
|
| Alleles | 1 | 2011 | 1681 | 0.060 |
Why?
|
| Middle Aged | 4 | 2024 | 28801 | 0.060 |
Why?
|
| Drug Therapy, Combination | 1 | 2009 | 1165 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 1685 | 0.060 |
Why?
|
| Peroxides | 1 | 2005 | 11 | 0.060 |
Why?
|
| Regulon | 1 | 2005 | 11 | 0.060 |
Why?
|
| Peroxiredoxins | 2 | 2005 | 10 | 0.060 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2025 | 67 | 0.060 |
Why?
|
| Amino Acid Sequence | 3 | 2000 | 2696 | 0.060 |
Why?
|
| Time Factors | 1 | 2015 | 6406 | 0.060 |
Why?
|
| Bacteroides thetaiotaomicron | 1 | 2024 | 9 | 0.060 |
Why?
|
| Natural Language Processing | 1 | 2025 | 72 | 0.060 |
Why?
|
| Acetylation | 1 | 2025 | 191 | 0.060 |
Why?
|
| Prevalence | 2 | 2024 | 2656 | 0.050 |
Why?
|
| Odds Ratio | 2 | 2019 | 1253 | 0.050 |
Why?
|
| Phylogeny | 2 | 2025 | 763 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2024 | 5140 | 0.050 |
Why?
|
| Glycolysis | 1 | 2024 | 168 | 0.050 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2023 | 28 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2025 | 211 | 0.050 |
Why?
|
| Respiratory Function Tests | 1 | 2024 | 214 | 0.050 |
Why?
|
| Genomic Imprinting | 1 | 2024 | 130 | 0.050 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2005 | 173 | 0.050 |
Why?
|
| Achievement | 1 | 2023 | 32 | 0.050 |
Why?
|
| Longevity | 1 | 2025 | 159 | 0.050 |
Why?
|
| Eosinophilia | 1 | 2024 | 106 | 0.050 |
Why?
|
| Logistic Models | 2 | 2019 | 1840 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2024 | 329 | 0.050 |
Why?
|
| DNA Modification Methylases | 1 | 2022 | 51 | 0.050 |
Why?
|
| Research Personnel | 1 | 2023 | 135 | 0.050 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2024 | 303 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 1 | 2024 | 1057 | 0.050 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2005 | 383 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 3731 | 0.050 |
Why?
|
| Health Surveys | 1 | 2023 | 259 | 0.050 |
Why?
|
| Biomarkers | 2 | 2025 | 3386 | 0.050 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2024 | 212 | 0.050 |
Why?
|
| Bias | 1 | 2022 | 144 | 0.050 |
Why?
|
| Single-Cell Analysis | 1 | 2025 | 355 | 0.040 |
Why?
|
| Administration, Inhalation | 1 | 2022 | 182 | 0.040 |
Why?
|
| Histones | 1 | 2025 | 541 | 0.040 |
Why?
|
| Aerobiosis | 1 | 2000 | 13 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2024 | 902 | 0.040 |
Why?
|
| Paraquat | 1 | 2000 | 14 | 0.040 |
Why?
|
| Feces | 1 | 2024 | 780 | 0.040 |
Why?
|
| Sex Factors | 1 | 2024 | 1350 | 0.040 |
Why?
|
| Drug Resistance, Microbial | 1 | 2000 | 197 | 0.040 |
Why?
|
| Myeloproliferative Disorders | 1 | 2021 | 91 | 0.040 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2022 | 337 | 0.040 |
Why?
|
| Pulmonary Emphysema | 1 | 2020 | 94 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2000 | 351 | 0.040 |
Why?
|
| Genome, Bacterial | 1 | 2000 | 213 | 0.040 |
Why?
|
| Ethanol | 1 | 2000 | 164 | 0.040 |
Why?
|
| Seroepidemiologic Studies | 1 | 2019 | 144 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 138 | 0.040 |
Why?
|
| Thyroidectomy | 1 | 2019 | 100 | 0.040 |
Why?
|
| Machine Learning | 1 | 2022 | 345 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2019 | 6506 | 0.040 |
Why?
|
| Algorithms | 1 | 2025 | 1712 | 0.040 |
Why?
|
| Electronic Health Records | 1 | 2025 | 804 | 0.040 |
Why?
|
| Carcinogenesis | 1 | 2021 | 359 | 0.040 |
Why?
|
| Poisson Distribution | 1 | 2017 | 51 | 0.030 |
Why?
|
| Nutrition Surveys | 1 | 2019 | 314 | 0.030 |
Why?
|
| Conserved Sequence | 2 | 1995 | 295 | 0.030 |
Why?
|
| Lung | 1 | 2025 | 1551 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2018 | 377 | 0.030 |
Why?
|
| Prognosis | 2 | 2018 | 4989 | 0.030 |
Why?
|
| Phenotype | 2 | 2012 | 4544 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2019 | 666 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2022 | 1054 | 0.030 |
Why?
|
| Sequence Alignment | 2 | 1995 | 619 | 0.030 |
Why?
|
| Gene Expression Regulation | 2 | 2016 | 2483 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2019 | 503 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 677 | 0.030 |
Why?
|
| Decalcification, Pathologic | 1 | 2016 | 2 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2018 | 1067 | 0.030 |
Why?
|
| Side-Population Cells | 1 | 2016 | 12 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2017 | 797 | 0.030 |
Why?
|
| Biopsy | 1 | 2019 | 1287 | 0.030 |
Why?
|
| Family Characteristics | 1 | 2016 | 91 | 0.030 |
Why?
|
| Income | 1 | 2016 | 136 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2016 | 236 | 0.030 |
Why?
|
| Pandemics | 1 | 2023 | 1186 | 0.030 |
Why?
|
| Eukaryotic Cells | 1 | 1995 | 31 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 242 | 0.030 |
Why?
|
| Educational Status | 1 | 2016 | 295 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2016 | 367 | 0.030 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 1995 | 79 | 0.030 |
Why?
|
| Age of Onset | 1 | 2016 | 626 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 1382 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 1995 | 220 | 0.030 |
Why?
|
| Immune System | 1 | 2014 | 96 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2016 | 263 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2016 | 750 | 0.030 |
Why?
|
| Multigene Family | 1 | 1995 | 310 | 0.030 |
Why?
|
| Virulence | 2 | 2005 | 279 | 0.030 |
Why?
|
| Bone and Bones | 1 | 2016 | 300 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2014 | 167 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 1960 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2014 | 303 | 0.030 |
Why?
|
| Genomics | 1 | 2021 | 1644 | 0.020 |
Why?
|
| Quality of Life | 1 | 2023 | 2146 | 0.020 |
Why?
|
| Neoplastic Stem Cells | 1 | 2014 | 348 | 0.020 |
Why?
|
| Leukemia | 1 | 2014 | 373 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2014 | 525 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 947 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 5368 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2014 | 1028 | 0.020 |
Why?
|
| Cell Count | 1 | 2010 | 233 | 0.020 |
Why?
|
| Genotype | 1 | 2016 | 2706 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2014 | 3060 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2016 | 3654 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2010 | 1226 | 0.010 |
Why?
|
| DNA Footprinting | 1 | 2005 | 14 | 0.010 |
Why?
|
| Oxidants | 1 | 2005 | 25 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 2005 | 495 | 0.010 |
Why?
|
| Young Adult | 1 | 2016 | 9929 | 0.010 |
Why?
|
| Zebrafish | 1 | 2004 | 421 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2005 | 1342 | 0.010 |
Why?
|
| Skin | 1 | 2004 | 540 | 0.010 |
Why?
|
| Protein Binding | 1 | 2005 | 1752 | 0.010 |
Why?
|
| Base Sequence | 1 | 2005 | 2986 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2005 | 799 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2004 | 3064 | 0.010 |
Why?
|
| Glucokinase | 1 | 1995 | 15 | 0.010 |
Why?
|
| Glycerol Kinase | 1 | 1995 | 19 | 0.010 |
Why?
|
| Genes, Helminth | 1 | 1995 | 22 | 0.010 |
Why?
|
| Carbohydrates | 1 | 1995 | 38 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1995 | 659 | 0.010 |
Why?
|
| Caenorhabditis elegans | 1 | 1995 | 242 | 0.010 |
Why?
|
| Software | 1 | 1995 | 726 | 0.010 |
Why?
|
| Databases, Factual | 1 | 1995 | 1231 | 0.000 |
Why?
|